山东立新制药有限公司
Shandong Lixin Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
8
9 products shown
🇺🇸 DMF
2
2 products shown
🇪🇺 CEP
3
3 products shown
Total
13
registrations
🇨🇳 CDE 注册 (9)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Capecitabine 卡培他滨 | 154361-50-9 | Class A | Y20170000125 |
| Clopidogrel 氯吡格雷 | 113665-84-2 | Class A | Y20210001051 |
| Esomeprazole Magnesium 埃索美拉唑镁 | 119141-88-7 | Class I | Y20230000158 |
| Idebenone 艾地苯醌 | 58186-27-9 | Class A | Y20240000348 |
| Methocarbamol 美索巴莫 | 532-03-6 | Class A | Y20230000362 |
| Nilotinib 盐酸尼洛替尼 | 641571-10-0 | Class A | Y20210000245 |
| Pregabalin 普瑞巴林 | 148553-50-8 | Class I | Y20250000894 |
| Pregabalin 普瑞巴林 | 148553-50-8 | Class I | Y20220000631 |
| Tenofovir Disoproxil 酒石酸替诺福韦二吡呋酯 | 201341-05-1 | Class A | Y20220001270 |
🇺🇸 DMF 注册 (2)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Molnupiravir 莫诺拉韦 | 2492423-29-5 | 37087 | 2022-05-06 |
| Nilotinib Hydrochloride Monohydrate | 923288-90-8 | 40014 | 2024-05-28 |
🇪🇺 CEP 注册 (3)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Capecitabine 卡培他滨 | 154361-50-9 | R0-CEP 2021-316 - Rev 00 | 2022-10-19 |
| Clopidogrel Hydrogen Sulfate | 120202-66-6 | CEP 2022-450 - Rev 00 | 2024-12-17 |
| Nilotinib Hydrochloride Monohydrate | 923288-90-8 | CEP 2021-133 - Rev 01 | 2025-01-29 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12